Smarter Biomanufacturing, validated by science

Get started today Learn more

Building Smarter Solutions for Biomanufacturing​

Optinome is a hybrid R&D-centric CDMO that uniquely integrates wet-lab process development with AI/ML-powered digital infrastructure to support biotech companies in scaling innovative biologics faster, smarter, and more predictably.

We specialize in CMC strategy, manufacturability evaluation, and scale-up readiness for Biologics (starting material, gene therapies, DNA/RNA-based products, antibodies, enzymes, microbial platforms, and synthetic biology innovations)

CMC Consultation & Strategy

  • Early-stage feasibility and manufacturability assessment
  • IND-enabling CMC package development and documentation
  • Regulatory roadmap planning and risk mitigation

Wet-Lab Bioprocess Development

  • 0.5–5L batch & fed-batch fermentations
  • Genetic construct and strain optimization
  • SOP design, validation, and quality analytics

AI-Powered Digital Platform

  • Simulation of manufacturing parameters
  • Predictive models for yield, purity, and batch success
  • Digital tools for process control and tech transfer
  • Structured batch data for regulatory alignment and reproducibility

Modular Engagement Models

  • Tailored packages for biotech startups, CDMOs, or academic spinouts
  • Pilot studies, service contracts, or full SaaS platform access

 Our Team

Our founding and leadership team brings over 40 years of combined, hands-on experience spanning drug development, biomanufacturing, and biotechnology commercialization, as well as AI, machine learning, genomics, proteomics, and fermentation science.

We are a team of scientists, engineers, and AI/ML innovators with a proven track record of translating complex science into scalable, high-value solutions.

United by a shared vision to advance precision biomanufacturing, we are building technologies that redefine efficiency, reliability, and sustainability in the biotech value chain.

Why Choose Us?

  • Accelerate GMP Readiness: Cut time from R&D to IND
  • De-Risk Scale-Up: Replace trial-and-error with predictive insights
  • Boost Reproducibility: SOPs + Digital Tools ensure consistency
  • Prepare for Tech Transfer: Digitized, traceable, validated processes
  • Investor & Regulatory Confidence: Structured, auditable data built for CMC